Coinfection with SARS-CoV-2 and influenza studied in hospitalized or deceased pediatric patients

This observational report examined SARS-CoV-2 and influenza coinfection in children and adolescents aged 18 years who were hospitalized or died with influenza in the United States. The study population was defined as pediatric patients with influenza who experienced hospitalization or death, but the sample size was not reported. No comparator group was specified, and the follow-up duration was not provided.

The main outcome assessed was pediatric hospitalizations and deaths associated with coinfection with SARS-CoV-2 and influenza. However, the specific results for this outcome were not reported, including effect size, absolute numbers, statistical significance, or direction of association. No secondary outcomes were listed in the available data.

Safety and tolerability information, including adverse events, serious adverse events, and discontinuations, was not reported. The report did not specify limitations of the evidence, and funding sources or potential conflicts of interest were not disclosed. Given the absence of reported results and key methodological details, this evidence has minimal direct practice relevance and should be interpreted with caution.